RNA · Atrium Therapeutics, Inc.
Market Cap
$233.32M
Shares
17.11M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.
Key facts
CIK
2093101
CUSIP
04965N104
13F (30d)
135 filings
133 filers
Visit website
Investor relations